Viral infections could activate the immune system through molecular mimicry leading to anti-GFAP antibody production, activation of GFAP-specific CD8+ T-cells, blood–brain barrier disruption, and cellular cytotoxicity leading to target cell apoptosis. Here, GFAP is linked to viral infectious disease.